Mettler-Toledo International (MTD) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 May, 2026Executive summary
Achieved 7% reported sales growth to $947.1 million in Q1 2026, with 3% local currency growth and 1% excluding acquisitions.
Adjusted EPS increased 9% to $8.91, supported by margin initiatives and innovation investments, while reported EPS was $8.33, up from $7.81.
Growth was led by strong industrial automation, food retailing, and bioprocessing segments, offset by softness in Western markets and chemical sectors.
Management remains confident in achieving solid adjusted EPS growth for the full year, with agility to navigate macroeconomic and geopolitical challenges.
Continued investment in innovation, automation, and digital tools positions the business for future growth.
Financial highlights
Net sales reached $947.1 million, up from $883.7 million in Q1 2025; gross profit was $555.8 million, with gross margin at 58.7%, down 80 bps year-over-year.
Adjusted operating profit was $246.2 million, up 4% year-over-year; adjusted operating margin at 26.0%, down 80 bps.
Net earnings for the quarter were $169.5 million, a 4% increase; diluted EPS was $8.33, up from $7.81.
Adjusted free cash flow was $119.7 million, impacted by higher tax payments; cash flow from operations was $139.8 million.
$206.3 million was spent on share repurchases in Q1 2026.
Outlook and guidance
Full-year 2026 local currency sales growth forecast at ~4%, with adjusted EPS guidance raised to $46.30–$46.95 (8–10% growth); FX expected to be a 2% sales benefit and neutral to EPS.
Q2 2026 local currency sales expected to grow ~3%, with adjusted EPS of $10.70–$10.85 (6–8% growth).
Free cash flow for 2026 expected at ~$900 million, up 5% per share; share repurchases of $825–$875 million planned.
Management expects sufficient liquidity for foreseeable needs, with ongoing monitoring of global trade, tariffs, and geopolitical risks.
Uncertainties from geopolitical conflicts and global tariffs may impact future results.
Latest events from Mettler-Toledo International
- Strong earnings, innovation, and China-led growth support a positive second-half outlook.MTD
Bank of America Global Healthcare Conference 202613 May 2026 - Annual meeting covers director elections, auditor ratification, and performance-based executive pay.MTD
Proxy Filing18 Mar 2026 - Director elections, auditor ratification, and say-on-pay vote set for May 7, 2026.MTD
Proxy Filing18 Mar 2026 - Q4 2025 saw 8% sales and EPS growth, with a strong 2026 outlook despite market headwinds.MTD
Q4 20256 Feb 2026 - Q2 sales fell 4%, but margin gains and service growth led to raised full-year guidance.MTD
Q2 20242 Feb 2026 - Q3 adjusted EPS up 4% on 1% sales growth; Laboratory and Service led gains amid soft markets.MTD
Q3 202415 Jan 2026 - Manufacturing flexibility, innovation, and operational programs drive growth and margin expansion.MTD
Stifel 2024 Healthcare Conference13 Jan 2026 - Innovation, digitalization, and margin expansion fuel global growth and shareholder value.MTD
44th Annual J.P. Morgan Healthcare Conference13 Jan 2026 - Lab and service growth offset China industrial softness; cautious 2025 outlook with service focus.MTD
7th Annual Evercore ISI HealthCONx Conference11 Jan 2026